Loss of miR-145 promotes remyelination and functional recovery in a model of chronic central demyelination

Commun Biol. 2024 Jul 4;7(1):813. doi: 10.1038/s42003-024-06513-x.

Abstract

Strategies for treating progressive multiple sclerosis (MS) remain limited. Here, we found that miR-145-5p is overabundant uniquely in chronic lesion tissues from secondary progressive MS patients. We induced both acute and chronic demyelination in miR-145 knockout mice to determine its contributions to remyelination failure. Following acute demyelination, no advantage to miR-145 loss could be detected. However, after chronic demyelination, animals with miR-145 loss demonstrated increased remyelination and functional recovery, coincident with altered presence of astrocytes and microglia within the corpus callosum relative to wild-type animals. This improved response in miR-145 knockout animals coincided with a pathological upregulation of miR-145-5p in wild-type animals with chronic cuprizone exposure, paralleling human chronic lesions. Furthermore, miR-145 overexpression specifically in oligodendrocytes (OLs) severely stunted differentiation and negatively impacted survival. RNAseq analysis showed altered transcriptome in these cells with downregulated major pathways involved in myelination. Our data suggest that pathological accumulation of miR-145-5p is a distinctive feature of chronic demyelination and is strongly implicated in the failure of remyelination, possibly due to the inhibition of OL differentiation together with alterations in other glial cells. This is mirrored in chronic MS lesions, and thus miR-145-5p serves as a potential relevant therapeutic target in progressive forms of MS.

MeSH terms

  • Animals
  • Chronic Disease
  • Cuprizone / toxicity
  • Demyelinating Diseases* / genetics
  • Demyelinating Diseases* / metabolism
  • Demyelinating Diseases* / pathology
  • Disease Models, Animal*
  • Female
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout*
  • MicroRNAs* / genetics
  • MicroRNAs* / metabolism
  • Myelin Sheath / metabolism
  • Oligodendroglia / metabolism
  • Oligodendroglia / pathology
  • Recovery of Function
  • Remyelination* / genetics

Substances

  • MicroRNAs
  • MIRN145a microRNA, mouse
  • MIRN145 microRNA, human
  • Cuprizone